Makenna Delaney & Sullivan, Inc. to assist the firm. W. Richard Ulmer (800) 2-INVITRO INVITRO
Company Looks Forward with Cautious Optimism Irvine, CA, May 5, 1998 — InVitro International’s (Bulletin
To Our Shareholders: InVitro International finished the 1997 fiscal year by recording its lowest quarterly
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Year Ended September 30, 1997 1996 Revenues $720,000 $1,063,000 Costs
Company Announces Lowest Quarterly Loss and Expands Merger Options Irvine, CA, August 15, 1997 —
Company Signs Merger Letter Of Intent With Miragen Irvine, CA, May 15, 1997 — InVitro
IRVINE, CA, March 3, 1997 — InVitro International (Nasdaq SmallCap Market Symbol “INVI”) today announced
Board Of Directors Defer Decision To Implement 1-For-10 Reverse Stock Split Recently Approved By Shareholders
$1.8 Million In INVI Sales To Result From Every 1 Percent Who Decide To Buy